Marker Therapeutics (MRKR) Revenue (2016 - 2025)
Marker Therapeutics (MRKR) reported Revenue of $1.1 million for Q4 2025, down 51.0% year-over-year from $2.3 million in Q4 2024, and down 10.5% quarter-over-quarter from $1.2 million in Q3 2025.
Marker Therapeutics (MRKR) Revenue (2016 - 2025) Analysis & Trends
Marker Therapeutics (MRKR) has 9 years of Revenue data on file, last reported at $1.1 million in Q4 2025.
- Revenue for Q4 2025 came in at $1.1 million, down 51.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.5 million (down 52.21% YoY), and the FY2025 annual result was $3.5 million, down 46.19% from the prior year.
- Revenue eased to $1.1 million in Q4 2025 per MRKR's latest filing, from $1.2 million in the prior quarter.
- Over five years, Revenue peaked at $2.5 million in Q1 2023 and troughed at -$503005.0 in Q2 2023.
- A 4-year average of $1.1 million and a median of $1.0 million in 2022 frame the typical range for Revenue.
- The sharpest annual moves came in 2023 and 2024: Revenue tumbled 163.63% in 2023, then soared 647.66% in 2024.
- A 4-year view of Revenue shows it stood at $759143.0 in 2022, then surged by 39.17% to $1.1 million in 2023, then soared by 113.13% to $2.3 million in 2024, then sank by 51.0% to $1.1 million in 2025.
- Business Quant data shows MRKR's Revenue at $1.1 million in Q4 2025, $1.2 million in Q3 2025, and $861184.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Marker Therapeutics | 28.20 Mn | 28.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.10 Mn |
| Sep 30, 2025 | 1.23 Mn |
| Jun 30, 2025 | 861,184.00 |
| Mar 31, 2025 | 349,104.00 |
| Dec 31, 2024 | 2.25 Mn |
| Sep 30, 2024 | 1.93 Mn |
| Jun 30, 2024 | 2.00 Mn |
| Mar 31, 2024 | 1.24 Mn |
| Dec 31, 2023 | 1.06 Mn |
| Sep 30, 2023 | 257,606.00 |
| Jun 30, 2023 | -503,005.00 |
| Mar 31, 2023 | 2.50 Mn |
| Dec 31, 2022 | 759,143.00 |
| Sep 30, 2022 | 999,571.00 |
| Jun 30, 2022 | 790,508.00 |
| Mar 31, 2022 | 964,322.00 |
| Jun 30, 2020 | 466,785.00 |
| Dec 31, 2019 | 200,000.00 |
| Jun 30, 2018 | 205,994.00 |
| Sep 30, 2017 | 183,064.00 |